HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.

Abstract
A consistent metabolic hallmark observed in multiple cancers is the increase of cellular phosphocholine (PC) and total choline-containing compounds (tCho), which is closely related to malignant transformation, invasion, and metastasis. Enzymes in choline phospholipid metabolism present attractive targets to exploit for treatment, but require a clear understanding of the mechanisms underlying the altered choline phospholipid metabolism observed in cancer. Choline kinase-α (Chk-α) is an enzyme in the Kennedy pathway that phosphorylates free choline (Cho) to PC, and its upregulation in several cancers is a major contributor to increased PC levels. Similarly, increased expression and activity of phospholipase D1 (PLD1), which converts phosphatidylcholine (PtdCho) to phosphatidic acid (PA) and Cho, has been well documented in gastric, ovarian and breast cancer. Here we report a strong correlation between expression of Chk-α and PLD1 with breast cancer malignancy. Data from patient samples established an association between estrogen receptor (ER) status and Chk-α and PLD1 expression. In addition, these two enzymes were found to be interactive. Downregulation of Chk-α with siRNA increased PLD1 expression, and downregulation of PLD1 increased Chk-α expression. Simultaneous silencing of PLD1 and Chk-α in MDA-MB-231 cells increased apoptosis as detected by the TUNEL assay. These data provide new insights into choline phospholipid metabolism of breast cancer, and support multiple targeting of enzymes in choline phospholipid metabolism as a strategy for treatment.
AuthorsMayur Gadiya, Noriko Mori, Maria D Cao, Yelena Mironchik, Samata Kakkad, Ingrid S Gribbestad, Kristine Glunde, Balaji Krishnamachary, Zaver M Bhujwalla
JournalCancer biology & therapy (Cancer Biol Ther) Vol. 15 Issue 5 Pg. 593-601 (May 2014) ISSN: 1555-8576 [Electronic] United States
PMID24556997 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • ESR1 protein, human
  • Estrogen Receptor alpha
  • Phosphatidylcholines
  • RNA, Messenger
  • RNA, Small Interfering
  • essential 303 forte
  • CHKA protein, human
  • Choline Kinase
  • Phospholipase D
  • phospholipase D1
Topics
  • Adult
  • Aged
  • Apoptosis (drug effects)
  • Breast Neoplasms (metabolism, pathology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Choline Kinase (genetics, metabolism)
  • Estrogen Receptor alpha (metabolism)
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Staging
  • Phosphatidylcholines (metabolism)
  • Phospholipase D (genetics, metabolism)
  • RNA, Messenger (metabolism)
  • RNA, Small Interfering (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: